Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01431209
What this trial is testing

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Nebraska 71
Large-scale testing (Phase 3)Study completedNCT01034163
What this trial is testing

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Early research (Phase 1)Ended earlyNCT02957032
What this trial is testing

The Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia, Relapsed, Adult
Philogen S.p.A. 30
Not applicableLooking for participantsNCT07791849
What this trial is testing

GMPA Versus PPI for Gastric Protection and aGVHD Risk

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)aGVHDInfection+2 more
First Affiliated Hospital of Zhejiang University 198
Large-scale testing (Phase 3)Looking for participantsNCT05509933
What this trial is testing

Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation

Who this might be right for
Engraftment Syndrome
Henry Ford Health System 110
Not applicableActive Not RecruitingNCT04635384
What this trial is testing

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
CareDx 307
Testing effectiveness (Phase 2)Study completedNCT00005941
What this trial is testing

Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Who this might be right for
Cervical CancerVaginal Cancer
Fred Hutchinson Cancer Center
Not applicableUnknownNCT04945954
What this trial is testing

Pharmacokinetic Study of Post-transplant Cyclophosphamide in Pediatric Patients

Who this might be right for
Hematopoietic Stem Cell Transplantation
Seoul National University Hospital 15
Large-scale testing (Phase 3)Looking for participantsNCT06972641
What this trial is testing

Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
AMLMDS
Ruijin Hospital 126
Large-scale testing (Phase 3)UnknownNCT05907486
What this trial is testing

The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Thrombotic Disorder
The First Affiliated Hospital of Soochow University 260
Not applicableUnknownNCT04078399
What this trial is testing

Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence

Who this might be right for
HSCTEfficacy and Safety
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Early research (Phase 1)Ended earlyNCT03286114
What this trial is testing

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University of Michigan Rogel Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT01959100
What this trial is testing

Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Malignant Hematological Diseases
Assistance Publique - Hôpitaux de Paris 480
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Not applicableEnded earlyNCT01327625
What this trial is testing

Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans

Who this might be right for
Graft vs Host DiseaseBronchiolitis Obliterans
Asan Medical Center 6
Not applicableStudy completedNCT05238376
What this trial is testing

Survivorship Post-HCT Optimization Program

Who this might be right for
Hematologic Malignancy
Duke University 16
Not applicableLooking for participantsNCT03810196
What this trial is testing

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes+5 more
Children's Hospital of Philadelphia 50
Next Page